| Bioactivity | Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. | ||||||||||||
| Invitro | Kif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation[1]. | ||||||||||||
| Name | Kif15-IN-2 | ||||||||||||
| CAS | 672926-33-9 | ||||||||||||
| Formula | C20H20N6O4S | ||||||||||||
| Molar Mass | 440.48 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Quinazolinedione derivatives useful for treating cellular proliferative disorders and disorders associated with Kif15 kinesin activity are described. US 20040053948 A1. |
Kif15-IN-2
CAS: 672926-33-9 F: C20H20N6O4S W: 440.48
Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.